NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

LC,

Thanks for asking. To be specific, most of your posts sound like sourceless and baseless innuendo.

The CEO once loaned NWBO millions from her own pocket to fund research into the DCVax-L technology. Of course, she was rewarded for loaning her own money, but her actions were a testament to her confidence and her long-term commitment. The leadership have been committed to the company long term and they are shareholders too.

Your vague reference to “ethics” seems defamatory absent of any supporting facts, in my view.

UCLA, King’s College, JAMA Oncology, and Brown University are some excellent sources that you might wish to consider in reference to the reputation of Northwest Biotherapeutics and those who choose to associate with the company, its SAB, and with the novel DCVax® technology.

The world-renowned doctors cited below worked on the P3, and they both were coauthors of a DCVax-L publication along with Dr. Bosch of Northwest Biotherapeutics.

Furthermore, both Liau and Ashkan have had the support of their respective nations’ governments over many years. Ashkan is an advisor to the UK government, and Liau’s work has been supported by NIH peer-reviewed grants for 20 consecutive years.

https://finance.yahoo.com/news/northwest-biotherapeutics-announces-dr-linda-140000962.html


https://labusinessjournal.com/healthcare/national-academy-medicine-taps-ucla-neurosurgeon/


https://pubmed.ncbi.nlm.nih.gov/33789235/

https://www.societyns.org/about/officers-detail/linda-m-liau-md-phd-mba-4

https://brownneurosurgery.com/breakthrough-brain-cancer-vaccine/

This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated with improved survival in both newly diagnosed & recurrent glioblastoma compared with matched controls who received SOC treatment. https://t.co/Uso7Pkh1Kt

— JAMA Oncology (@JAMAOnc) February 15, 2023

#dcvax #allsolidtumors $nwbo #gbm

Great to see, congratulations Linda Liau winning the Charles B. Wilson Excellence Award 2023:

Established by the Brain Tumor Society in 2004, this award recognizes outstanding contributions of a clinician to the field of neuro-oncology.… pic.twitter.com/6L7rhyoNU4

— Peter Davis (@peter_brit) October 3, 2023

https://www.kch.nhs.uk/news/kings-team-wins-professional-excellence-award/

🧠 This weekend, read about Professor Keyoumars Ashkan, Consultant Neurosurgeon at King's, who met with his patient Dagmar Turner after her #BrainSurgery - their experience is showcased at the @HunterianLondon.

Read #InsideKings ➡️ https://t.co/mKmO2Hbp4J pic.twitter.com/TZdCDnfXyJ

— King's College NHS (@KingsCollegeNHS) September 2, 2023